Randomized Controlled Trial of Physical Exercise in Diabetic Veterans With Length-Dependent Distal Symmetric Polyneuropathy

Evan B Stubbs Jr, Morris A Fisher, Clara M Miller, Christine Jelinek, Jolene Butler, Conor McBurney, Eileen G Collins, Evan B Stubbs Jr, Morris A Fisher, Clara M Miller, Christine Jelinek, Jolene Butler, Conor McBurney, Eileen G Collins

Abstract

Rationale: Physical exercise is an essential adjunct to the management of patients with type 2 diabetes mellitus. Therapeutic interventions that improve blood flow to peripheral nerves, such as exercise, may slow the progression of neuropathy in the diabetic patient. Aims: This randomized clinical trial was conducted to determine whether a structured program of aerobic, isokinetic strength, or the combination of aerobic-isokinetic strength exercise intervention alters peripheral nerve function in glycemic-controlled diabetic patients with advanced length-dependent distal symmetric polyneuropathy. Methods: Forty-five patients with type 2 diabetes mellitus exhibiting tight glycemic control (HbA1c intergroup range 7.2-8.0%) were randomized by block design across four experimental groups: sedentary controls (n = 12), aerobic exercise (n = 11), isokinetic strength (n = 11), or the combination of aerobic-isokinetic strength training (n = 11). Patients randomized to training groups exercised 3× per week for 12 weeks, whereas patients randomized to the sedentary control group received standard of care. To minimize attention and educational bias, all patients attended a 12-session health promotion educational series. At baseline, immediately following intervention, and again at 12-week post-intervention, detailed nerve conduction studies were conducted as a primary outcome measure. At these same intervals, all patients completed as secondary measures quantitative sensory testing, symptom-limited treadmill stress tests, and a Short-Form 36-Veterans Questionnaire (SF-36V). Results: Of the 45 patients randomized into this study, 37 (82%) had absent sural nerve responses, 19 (42%) had absent median sensory nerve responses, and 17 (38%) had absent ulnar sensory nerve responses. By comparison, responses from tibial nerves were absent in only three (7%) subjects while responses from peroneal nerves were absent in five (11%) subjects. Eleven (92%) of 12 patients that had volunteered to be biopsied exhibited abnormal levels of epidermal nerve fiber densities. Exercise, regardless of type, did not alter sensory or motor nerve electrodiagnostic findings among those patients exhibiting measurable responses (ANOVA). There was, however, a modest (p = 0.01) beneficial effect of exercise on sensory nerve function (Fisher's Exact Test). Importantly, the beneficial effect of exercise on sensory nerve function was enhanced (p = 0.03) during the post-intervention interval. In addition, three of six patients that had undergone exercise intervention exhibited a marked 1.9 ± 0.3-fold improvement in epidermal nerve fiber density. By comparison, none of three sedentary patients whom agreed to be biopsied a second time showed improvement in epidermal nerve fiber density. Compared to baseline values within groups, and compared with sedentary values across groups, neither aerobic, isokinetic strength, or the combination of aerobic-isokinetic strength exercise intervention altered peak oxygen uptake. Patients that underwent aerobic or the combined aerobic-isokinetic strength exercise intervention, however, demonstrated an increase in treadmill test duration that was sustained over the 12-week post-intervention period. Conclusion: A 12-week course of physical exercise, regardless of type, does not alter sensory or motor nerve electrodiagnostic findings. In a subset of patients, a short-term structured program of aerobic exercise may selectively improve sensory nerve fiber function. Large-scale exercise lifestyle intervention trials are warranted to further evaluate the impact of aerobic exercise on sensory nerve fiber function in diabetic neuropathic patients. Clinical Trial Registration: www.ClinicalTrials.gov, identifier NCT00955201.

Keywords: diabetes; exercise; human; metabolic; nerve conduction studies; peripheral nerve.

Figures

FIGURE 1
FIGURE 1
Flow diagram of study design.
FIGURE 2
FIGURE 2
Flow diagram of patient enrollment, randomization, and participation.
FIGURE 3
FIGURE 3
Exercise selectively elicits a sustained increase in SF-36V patient self-reported physical component score. Data shown are the means ± SD of self-reported responses from patients randomized to sedentary control (open bars) or combined exercise (solid bars) experimental groups. (A) Physical or (B) mental component scores are expressed as a percentage of weighted score (Supplementary Table S2) determined at entry into the study (baseline), immediately following intervention, and again at 12-week post-intervention of N responding patients, as indicated. Non-parametric data were analyzed by ANOVA on ranks (Kruskal–Wallis test). N.S., not significant. Note that one patient randomized to exercise did not complete the 12-week post SF-36V questionnaire.
FIGURE 4
FIGURE 4
Aerobic exercise selectively elicits improved treadmill endurance times. Data shown are the median, interquartile range, and minimum–maximum range of patient treadmill endurance times at (A) entry into the study (baseline), (B) immediately following intervention, and again at (C) 12-week post-intervention of N responding patients, as indicated. Parametric data were analyzed by two-way ANOVA with Tukey’s multiple comparison post hoc analysis. At baseline, all groups were statistically indistinguishable. Patients that had received aerobic training exhibited a strong statistical trend (p = 0.07) toward prolonged treadmill endurance times that was sustained (p = 0.02) when compared to those patients that had received strength training alone.
FIGURE 5
FIGURE 5
Group analyses of the effect of exercise on ulnar sensory nerve evoked electrodiagnostic parameters. Data shown are the median, interquartile range, and minimum–maximum range of latency, amplitude, and calculated conduction velocity elicited from antidromic stimulation of ulnar sensory nerves at entry into the study (baseline), immediately following intervention, and again at 12-week post-intervention of responding patients, as indicated. Parametric data were analyzed by two-way ANOVA with Tukey’s multiple comparison post hoc analysis. The total number of patients with measurable responses at baseline (sedentary controls, N = 8; exercise, N = 20), immediately following intervention (sedentary controls, N = 6; exercise, N = 16), and at 12-week post-intervention (sedentary controls, N = 7; exercise, N = 21) were group analyzed. At all three time points evaluated, there was no significant differences observed within and across experimental groups.
FIGURE 6
FIGURE 6
Group analyses of the effect of exercise on median sensory nerve evoked electrodiagnostic parameters. Data shown are the median, interquartile range, and minimum–maximum range of latency, amplitude, and calculated conduction velocity elicited from antidromic stimulation of median sensory nerves at entry into the study (baseline), immediately following intervention, and again at 12-week post-intervention of responding patients, as indicated. Parametric data were analyzed by two-way ANOVA with Tukey’s multiple comparison post hoc analysis. The total number of patients with measurable responses at baseline (sedentary controls, N = 5; exercise, N = 21), immediately following intervention (sedentary controls, N = 4; exercise, N = 18), and at 12-week post-intervention (sedentary controls, N = 6; exercise, N = 17) were group analyzed. At all three time points evaluated, there was no significant differences observed within and across experimental groups.
FIGURE 7
FIGURE 7
Group analyses of the effect of exercise on tibial nerve evoked electrodiagnostic parameters. Data shown are the median, interquartile range, and minimum–maximum range of latency, amplitude, and calculated conduction velocity elicited from antidromic stimulation of tibial nerves at entry into the study (baseline), immediately following intervention, and again at 12-week post-intervention of responding patients, as indicated. Parametric data were analyzed by two-way ANOVA with Tukey’s multiple comparison post hoc analysis. The total number of patients with measurable responses at baseline (sedentary controls, N = 11; exercise, N = 31), immediately following intervention (sedentary controls, N = 9; exercise, N = 27), and at 12-week post-intervention (sedentary controls, N = 8; exercise, N = 26) were group analyzed. At all three time points evaluated, there was no significant differences observed within and across experimental groups.
FIGURE 8
FIGURE 8
Group analyses of the effect of exercise on peroneal nerve evoked electrodiagnostic parameters. Data shown are the median, interquartile range, and minimum–maximum range of latency, amplitude, and calculated conduction velocity elicited from antidromic stimulation of peroneal nerves at entry into the study (baseline), immediately following intervention, and again at 12-week post-intervention of responding patients, as indicated. Parametric data were analyzed by two-way ANOVA with Tukey’s multiple comparison post hoc analysis. The total number of patients with measurable responses at baseline (sedentary controls, N = 10; exercise, N = 30), immediately following intervention (sedentary controls, N = 8; exercise, N = 26), and at 12-week post-intervention (sedentary controls, N = 7; exercise, N = 26) were group analyzed. At all three time points evaluated, there was no significant differences observed within and across experimental groups.

References

    1. Abbott C. A., Malik R. A., van Ross E. R., Kulkarni J., Boulton A. J. (2011). Prevalence and characteristics of painful diabetic neuropathy in a large community-based diabetic population in the U.K. Diabet. care 34 2220–2224. 10.2337/dc11-1108
    1. ADVANCE Collaborative Group Patel A., MacMahon S., Chalmers J., Neal B., Billot L., et al. (2008). Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N. Engl. J. Med. 358 2560–2572. 10.1056/NEJMoa0802987
    1. Alleman C. J., Westerhout K. Y., Hensen M., Chambers C., Stoker M., Long S., et al. (2015). Humanistic and economic burden of painful diabetic peripheral neuropathy in Europe: a review of the literature. Diabet. Res. Clin. Pract 109 215–225. 10.1016/j.diabres.2015.04.031
    1. American Diabetes Association (2014). Standards of medical care in diabetes–2014. Diabet. Care 37(Suppl. 1), S14–S80. 10.2337/dc14-S014
    1. Bacchi E., Negri C., Zanolin M. E., Milanese C., Faccioli N., Trombetta M., et al. (2012). Metabolic effects of aerobic training and resistance training in type 2 diabetic subjects: a randomized controlled trial (the RAED2 study). Diabet. Care 35 676–682. 10.2337/dc11-1655
    1. Banerjee A. K., Mandal A., Chanda D., Chakraborti S. (2003). Oxidant, antioxidant and physical exercise. Mol. Cell. Biochem. 253 307–312. 10.1023/A:1026032404105
    1. Boa B. C., Costa R. R., Souza M. G., Cyrino F. Z., Paes L. S., Miranda M. L., et al. (2014). Aerobic exercise improves microvascular dysfunction in fructose fed hamsters. Microvasc. Res. 93 34–41. 10.1016/j.mvr.2014.02.012
    1. Bongaerts B. W., Rathmann W., Heier M., Kowall B., Herder C., Stöckl D., et al. (2013). Older subjects with diabetes and prediabetes are frequently unaware of having distal sensorimotor polyneuropathy: the KORA F4 study. Diabet. Care 36 1141–1146. 10.2337/dc12-0744
    1. Boule N. G., Haddad E., Kenny G. P., Wells G. A., Sigal R. J. (2001). Effects of exercise on glycemic control and body mass in type 2 diabetes mellitus: a meta-analysis of controlled clinical trials. JAMA 286 1218–1227. 10.1001/jama.286.10.1218
    1. Boussageon R., Bejan-Angoulvant T., Saadatian-Elahi M., Lafont S., Bergeonneau C., Kassaï B., et al. (2011). Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials. BMJ 343:d4169. 10.1136/bmj.d4169
    1. Bril V., Ellison R., Ngo M., Bergstrom B., Raynard D., Gin H. (1998). Electrophysiological monitoring in clinical trials. Roche Neuropathy Study Group. Muscle Nerve 21 1368–1373. 10.1002/(SICI)1097-4598(199811)21:11<1368::AID-MUS2>;2-7
    1. Cade W. T. (2008). Diabetes-related microvascular and macrovascular diseases in the physical therapy setting. Phys. Ther. 88 1322–1335. 10.2522/ptj.20080008
    1. Castaneda C., Layne J. E., Munoz-Orians L., Gordon P. L., Walsmith J., Foldvari M., et al. (2002). A randomized controlled trial of resistance exercise training to improve glycemic control in older adults with type 2 diabetes. Diabet. Care 25 2335–2341. 10.2337/diacare.25.12.2335
    1. Cauza E., Hanusch-Enserer U., Strasser B., Ludvik B., Metz-Schimmerl S., Pacini G., et al. (2005). The relative benefits of endurance and strength training on the metabolic factors and muscle function of people with type 2 diabetes mellitus. Arch. Phys. Med. Rehabil. 86 1527–1533. 10.1016/j.apmr.2005.01.007
    1. Cefalu W. T. (2012). Evolving treatment strategies for the management of type 2 diabetes. Am. J. Med. Sci. 343 21–26. 10.1097/MAJ.0b013e31823ea4af
    1. Chawla A., Chawla R., Jaggi S. (2016). Microvasular and macrovascular complications in diabetes mellitus: distinct or continuum? Indian J. Endocrinol. Metab. 20 546–551. 10.4103/2230-8210.183480
    1. Chen S., Andary M., Buschbacher R., Del Toro D, Smith B., So Y., et al. (2016). Electrodiagnostic reference values for upper and lower limb nerve conduction studies in adult populations. Muscle Nerve 54 371–377. 10.1002/mus.25203
    1. Church T. S., Blair S. N., Cocreham S., Johannsen N., Johnson W., Kramer K., et al. (2010). Effects of aerobic and resistance training on hemoglobin A1c levels in patients with type 2 diabetes: a randomized controlled trial. JAMA 304 2253–2262. 10.1001/jama.2010.1710
    1. Colberg S. R., Albright A. L., Blissmer B. J., Braun B., Chasan-Taber L., Fernhall B., et al. (2010a). Exercise and type 2 diabetes: American College of Sports Medicine and the American Diabetes Association: joint position statement. Exercise and type 2 diabetes. Med. Sci. Sports Exerc. 42 2282–2303. 10.1249/MSS.0b013e3181eeb61c
    1. Colberg S. R., Sigal R. J., Fernhall B., Regensteiner J. G., Blissmer B. J., Rubin R. R., et al. (2010b). Exercise and type 2 diabetes: the American College of Sports Medicine and the American Diabetes Association: joint position statement. Diabet. Care 33 e147–e167. 10.2337/dc10-9990
    1. Colberg S. R., Sigal R. J., Yardley J. E., Riddell M. C., Dunstan D. W., Dempsey P. C., et al. (2016). Physical activity/exercise and diabetes: a position statement of the American Diabetes Association. Diabet. Care 39 2065–2079. 10.2337/dc16-1728
    1. Cooper M. A., Kluding P. M., Wright D. E. (2016). Emerging relationships between exercise, sensory nerves, and neuropathic pain. Front. Neurosci. 10:372. 10.3389/fnins.2016.00372
    1. DeSouza C. A., Shapiro L. F., Clevenger C. M., Dinenno F. A., Monahan K. D., Tanaka H., et al. (2000). Regular aerobic exercise prevents and restores age-related declines in endothelium-dependent vasodilation in healthy men. Circulation 102 1351–1357. 10.1161/01.CIR.102.12.1351
    1. Diabetes Control and Complications Trial Research Group Nathan D. M., Genuth S., Lachin J., Cleary P., Crofford O., et al. (1993). The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med. 329 977–986. 10.1056/NEJM199309303291401
    1. Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group Lachin J. M., Genuth S., Cleary P., Davis M. D., Nathan D. M., et al. (2000). Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. N. Engl. J. Med. 342 381–389. 10.1056/NEJM200002103420603
    1. Diabetes Prevention Program Research Group Knowler W. C., Fowler S. E., Hamman R. F., Christophi C. A., Hoffman H. J., et al. (2009). 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet 374 1677–1686. 10.1016/S0140-6736(09)61457-4
    1. Dillingham T., Chen S., Andary M., Buschbacher R., Del Toro D, Smith B., et al. (2016). Establishing high-quality reference values for nerve conduction studies: a report from the normative data task force of the American Association Of Neuromuscular & Electrodiagnostic Medicine. Muscle Nerve 54 366–370. 10.1002/mus.25204
    1. Duckworth W., Abraira C., Moritz T., Reda D., Emanuele N., Reaven P. D., et al. (2009). Glucose control and vascular complications in veterans with type 2 diabetes. N. Engl. J. Med. 360 129–139. 10.1056/NEJMoa0808431
    1. Dunstan D. W., Daly R. M., Owen N., Jolley D., De Courten M, Shaw J., et al. (2002). High-intensity resistance training improves glycemic control in older patients with type 2 diabetes. Diabet. Care 25 1729–1736. 10.2337/diacare.25.10.1729
    1. Dyck P. J., Albers J. W., Wolfe J., Bolton C. F., Walsh N., Klein C. J., et al. (2013). A trial of proficiency of nerve conduction: greater standardization still needed. Muscle Nerve 48 369–374. 10.1002/mus.23765
    1. Fisher M. A., Langbein W. E., Collins E. G., Williams K., Corzine L. (2007). Physiological improvement with moderate exercise in type II diabetic neuropathy. Electromyogr. Clin. 47 23–28.
    1. Fowler M. J. (2008). Microvascular and macrovascular complications of diabetes. Clin. Diabet. 26 77–82. 10.2337/diaclin.26.2.77x
    1. Goncalves N. P., Vægter C. B., Pallesen L. T. (2018). Peripheral glial cells in the development of diabetic neuropathy. Front. Neurol. 9:268 10.3389/fneur.2018.00268
    1. Green D. J., Maiorana A., O’Driscoll G., Taylor R. (2004). Effect of exercise training on endothelium-derived nitric oxide function in humans. J. Physiol. 561 1–25. 10.1113/jphysiol.2004.068197
    1. Gregg E. W., Chen H., Wagenknecht L. E., Clark J. M., Delahanty L. M., Bantle J., et al. (2012). Association of an intensive lifestyle intervention with remission of type 2 diabetes. JAMA 308 2489–2496. 10.1001/jama.2012.67929
    1. Hambrecht R., Adams V., Erbs S., Linke A., Kränkel N., Shu Y., et al. (2003). Regular physical activity improves endothelial function in patients with coronary artery disease by increasing phosphorylation of endothelial nitric oxide synthase. Circulation 107 3152–3158. 10.1161/01.CIR.0000074229.93804.5C
    1. Houston D. K., Neiberg R. H., Miller M. E., Hill J. O., Jakicic J. M., Johnson K. C., et al. (2017). Physical function following a long-term lifestyle intervention among middle aged and older adults with type 2 diabetes: the Look AHEAD Study. J. Gerontol. Ser. A Biol. Sci. Med. Sci. 73 1552–1559. 10.1093/gerona/glx204
    1. Ismail-Beigi F., Craven T., Banerji M. A., Basile J., Calles J., Cohen R. M., et al. (2010). Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial. Lancet 376 419–430. 10.1016/S0140-6736(10)60576-4
    1. Javed S., Alam U., Malik R. A. (2015). Treating diabetic neuropathy: present strategies and emerging solutions. Rev. Diabet. Stud. 12 63–83. 10.1900/RDS.2015.12.63
    1. Kazis L. E., Miller D. R., Clark J., Skinner K., Lee A., Rogers W., et al. (1998). Health-related quality of life in patients served by the Department of Veterans Affairs: results from the Veterans Health Study. Arch. Intern. Med. 158 626–632. 10.1001/archinte.158.6.626
    1. Kazis L. E., Miller D. R., Skinner K. M., Lee A., Ren X. S., Clark J. A., et al. (2006). Applications of methodologies of the Veterans Health Study in the VA healthcare system: conclusions and summary. J. Ambul. Care Manag. 29 182–188. 10.1097/00004479-200604000-00011
    1. Knauf M. T., Koltyn K. F. (2014). Exercise-induced modulation of pain in adults with and without painful diabetic neuropathy. J. Pain 15 656–663. 10.1016/j.jpain.2014.02.008
    1. Knowler W. C., Barrett-Connor E., Fowler S. E., Hamman R. F., Lachin J. M., Walker E. A., et al. (2002). Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N. Engl. J. Med. 346 393–403. 10.1056/NEJMoa012512
    1. Koltyn K. F. (2000). Analgesia following exercise: a review. Sports Med. 29 85–98. 10.2165/00007256-200029020-00002
    1. Langbein W. E., Collins E. G., Orebaugh C., Maloney C., Williams K. J., Littooy F. N., et al. (2002). Increasing exercise tolerance of persons limited by claudication pain using polestriding. J. Vasc. Surg. 35 887–893. 10.1067/mva.2002.123756
    1. Leardini-Tristão M., Borges J. P., Freitas F., Rangel R., Daliry A., Tibiriçá E., et al. (2017). The impact of early aerobic exercise on brain microvascular alterations induced by cerebral hypoperfusion. Brain Res. 1657 43–51. 10.1016/j.brainres.2016.11.030
    1. Leehey D. J., Collins E., Kramer H. J., Cooper C., Butler J., McBurney C., et al. (2016). Structured exercise in obese diabetic patients with chronic kidney disease: a randomized controlled trial. Am. J. Nephrol. 44 54–62. 10.1159/000447703
    1. Li G., Zhang P., Wang J., Gregg E. W., Yang W., Gong Q., et al. (2008). The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study. Lancet 371 1783–1789. 10.1016/S0140-6736(08)60766-7
    1. Lindström J., Ilanne-Parikka P., Peltonen M., Aunola S., Eriksson J. G., Hemiö K., et al. (2006). Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study. Lancet 368 1673–1679. 10.1016/S0140-6736(06)69701-8
    1. Look A. R. G. (2017). Effects of a long-term lifestyle modification programme on peripheral neuropathy in overweight or obese adults with type 2 diabetes: the Look AHEAD study. Diabetologia 60 980–988. 10.1007/s00125-017-4253-z
    1. Martin C. L., Albers J., Herman W. H., Cleary P., Waberski B., Greene D. A., et al. (2006). Neuropathy among the diabetes control and complications trial cohort 8 years after trial completion. Diabet. Care 29 340–344. 10.2337/diacare.29.02.06.dc05-1549
    1. Martin C. L., Albers J. W., Pop-Busui R., Group D. E. R. (2014). Neuropathy and related findings in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study. Diabet. Care 37 31–38. 10.2337/dc13-2114
    1. Nakuda H. (2014). Ischemia and diabetic neuropathy. Handbook Clin. Neurol. 126 469–487. 10.1016/B978-0-444-53480-4.00023-0
    1. National Diabetes Statistics Report (2017). Available at:
    1. Pan X. R., Li G. W., Hu Y. H., Wang J. X., Yang W. Y., An Z. X., et al. (1997). Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabet. care 20 537–544. 10.2337/diacare.20.4.537
    1. Pop-Busui R., Boulton A. J., Feldman E. L., Bril V., Freeman R., Malik R. A., et al. (2017). Diabetic neuropathy: a position statement by the American Diabetes Association. Diabet. Care 40 136–154. 10.2337/dc16-2042
    1. Ramachandran A., Snehalatha C., Mary S., Mukesh B., Bhaskar A. D., Vijay V., et al. (2006). The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). Diabetologia 49 289–297. 10.1007/s00125-005-0097-z
    1. Sacks D. B., Arnold M., Bakris G. L., Bruns D. E., Horvath A. R., Kirkman M. S., et al. (2011). Position statement executive summary: guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Diabet. Care 34 1419–1423. 10.2337/dc11-9997
    1. Shankarappa S. A., Piedras-Renteria E. S., Stubbs E. B., Jr. (2011). Forced-exercise delays neuropathic pain in experimental diabetes: effects on voltage-activated calcium channels. J. Neurochem. 118 224–236. 10.1111/j.1471-4159.2011.07302.x
    1. Sigal R. J., Kenny G. P., Wasserman D. H., Castaneda-Sceppa C. (2004). Physical activity/exercise and type 2 diabetes. Diabet. Care 27 2518–2539. 10.2337/diacare.27.10.2518
    1. Singleton J. R., Marcus R. L., Jackson J. E., K Lessard M., Graham T. E., Smith A. G. (2014). Exercise increases cutaneous nerve density in diabetic patients without neuropathy. Ann. Clin. Transl. Neurol. 1 844–849. 10.1002/acn3.125
    1. Singleton J. R., Marcus R. L., Lessard M. K., Jackson J. E., Smith A. G. (2015). Supervised exercise improves cutaneous reinnervation capacity in metabolic syndrome patients. Ann. Neurol. 77 146–153. 10.1002/ana.24310
    1. Smith A. G., Singleton J. R. (2012). Diabetic neuropathy. Continuum 18 60–84. 10.1212/01.CON.0000411568.34085.3e
    1. Stanford K. I., Goodyear L. J. (2014). Exercise and type 2 diabetes: molecular mechanisms regulating glucose uptake in skeletal muscle. Adv. Physiol. Educ. 38 308–314. 10.1152/advan.00080.2014
    1. Stratton I. M., Adler A. I., Neil H. A., Matthews D. R., Manley S. E., Cull C. A., et al. (2000). Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 321 405–412. 10.1136/bmj.321.7258.405
    1. Tesfaye S., Boulton A. J., Dyck P. J., Freeman R., Horowitz M., Kempler P., et al. (2010). Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabet. Care 33 2285–2293. 10.2337/dc10-1303
    1. Tuomilehto J., Lindström J., Eriksson J. G., Valle T. T., Hämäläinen H., Ilanne-Parikka P., et al. (2001). Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N. Engl. J. Med. 344 1343–1350. 10.1056/NEJM200105033441801
    1. van Dijk J. W., van Loon L. J. (2015). Exercise strategies to optimize glycemic control in type 2 diabetes: a continuing glucose monitoring perspective. Diabet. Spectr. 28 24–31. 10.2337/diaspect.28.1.24
    1. Vinik A., Emir B., Cheung R., Whalen E. (2013). Relationship between pain relief and improvements in patient function/quality of life in patients with painful diabetic peripheral neuropathy or postherpetic neuralgia treated with pregabalin. Clin. Ther. 35 612–623. 10.1016/j.clinthera.2013.03.008
    1. Vinik A. I., Erbas T. (2013). Diabetic autonomic neuropathy. Handb. Clin. Neurol. 117 279–294. 10.1016/B978-0-444-53491-0.00022-5
    1. World population data sheet-Population Reference Bureau (2017). Available at:
    1. Young M. J., Boulton A. J., MacLeod A. F., Williams D. R., Sonksen P. H. (1993). A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia 36 150–154. 10.1007/BF00400697
    1. Ziegler D., Rathmann W., Dickhaus T., Meisinger C., Mielck A., Group K. S. (2008). Prevalence of polyneuropathy in pre-diabetes and diabetes is associated with abdominal obesity and macroangiopathy: the MONICA/KORA Augsburg Surveys S2 and S3. Diabet. Care 31 464–469. 10.2337/dc07-1796

Source: PubMed

3
订阅